Stay updated with breaking news from Dan Visage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05.01.2023 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced favorable coverage policies from four commercial payers including Blue Cross Blue Shield ... Seite 1
/PRNewswire/ -- BioIQ, Inc., ("BioIQ") an analytics-driven population health and testing platform company for top employers, health plans, and government...
/PRNewswire/ -- BioIQ, Inc., ("BioIQ") an analytics-driven population health and testing platform company for top employers, health plans, and government...
DermTech Enters Into Agreement With Blue Shield of California DermTech Enters Into Agreement With Blue Shield of California DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it has entered into an agreement, effective February 1, 2021, with Blue Shield of California for reimbursement coverage for all of its products. Blue Shield of California has approximately 3.7 million covered lives in California through its Commercial PPO/EPO, Medicare Advantage PPO, Commercial HMO and Medicare Advantage HMO progr...